Serum sickness is a classic example of a type III hypersensitivity reaction, which usually develops as a complication of antitoxin or antivenom administration.

Epidemiology


Etiology

  • Antivenom or antitoxin containing animal proteins or serum (→ “serum” sickness), such as:
    • Equine anti-snake venom
    • Equine anti-spider venom
    • Equine or bovine anti-rabies antitoxin
    • Equine botulinum antitoxin
  • Medications: most frequently antibiotics (e.g., penicillin, amoxicillin, cefaclor, trimethoprim-sulfamethoxazole)
  • Infections: Hepatitis B virus

Pathophysiology

Exposure to an antigen (e.g., antivenom, drug) → formation of antibodies → deposition of antibody-antigen complexes in tissue → activation of the complement cascade → tissue damage and systemic inflammation


Clinical features

  • Fever
  • Rash (urticarial or purpuric)
  • Arthralgias, myalgia
  • Lymphadenopathy

Tip

Symptoms appear 1–3 weeks following initial exposure (because antibodies take several days to form) and typically resolve within a few weeks after discontinuation of the offending agent.


Diagnostics

  • Histologic examination of affected tissues typically shows small vessel vasculitis with fibrinoid necrosis and intense neutrophil infiltration.
  • Deposition of IgG and/or IgM complement-fixing antibodies results in localized complement consumption and hypocomplementemia (decreased serum C3 levels).

Differential Diagnostics

Serum sickness-like reaction

  • Epidemiology: much more common than actual serum sickness
  • Etiology: similar to that of serum sickness
    • Infections (e.g., hepatitis B, rabies)
    • Medications that can act as haptens (e.g., allopurinol, cephalosporins, penicillin)
  • Pathogenesis: unclear (likely not the result of a type III hypersensitivity reaction)
  • Clinical features
    • Similar to classic serum sickness

Treatment